|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA A Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
3
|
Babjuk M, Oosterlinck W, Sylvester R,
Kaasinen E, Böhle A, Palou-Redorta J and Rouprêt M; European
Association of Urology (EAU): EAU guidelines on non-muscle-invasive
urothelial carcinoma of the bladder, the 2011 update. Eur Urol.
59:997–1008. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Milowsky MI, Stadler WM and Bajorin DF:
Integration of neoadjuvant and adjuvant chemotherapy and cystectomy
in the treatment of muscle-invasive bladder cancer. BJU Int.
102:1339–1344. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stein JP, Lieskovsky G, Cote R, Groshen S,
Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M,
et al: Radical cystectomy in the treatment of invasive bladder
cancer: Long-term results in 1,054 patients. J Clin Oncol.
19:666–675. 2001.PubMed/NCBI
|
|
6
|
Shariat SF, Karakiewicz PI, Palapattu GS,
Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ,
Sagalowsky AI, et al: Outcomes of radical cystectomy for
transitional cell carcinoma of the bladder: A contemporary series
from the bladder cancer research consortium. J Urol. 176:2414–2422.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu RJ, Stein JP, Cai J, Miranda G, Groshen
S and Skinner DG: Superficial (pT2a) and deep (pT2b) muscle
invasion in pathological staging of bladder cancer following
radical cystectomy. J Urol. 176:493–498. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nieder AM, Simon MA, Kim SS, Manoharan M
and Soloway MS: Radical cystectomy after bacillus Calmette-Guérin
for high-risk Ta, T1 and carcinoma in situ: Defining the risk of
initial bladder preservation. Urology. 67:737–741. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu WW, Chang E, Drezek R and Colvin VL:
Water-soluble quantum dots for biomedical applications. Biochem
Biophys Res Commun. 348:781–786. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Larson DR, Zipfel WR, Williams RM, Clark
SW, Bruchez MP, Wise FW and Webb WW: Water-soluble quantum dots for
multiphoton fluorescence imaging in vivo. Science. 300:1434–1436.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Akerman ME, Chan WC, Laakkonen P, Bhatia
SN and Ruoslahti E: Nanocrystal targeting in vivo. Proc Natl Acad
Sci USA. 99:12617–12621. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Algar WR, Tavares AJ and Krull UJ: Beyond
labels: A review of the application of quantum dots as integrated
components of assays, bioprobes, and biosensors utilizing optical
transduction. Anal Chim Acta. 673:1–25. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rosenthal SJ, Chang JC, Kovtun O, McBride
JR and Tomlinson ID: Biocompatible quantum dots for biological
applications. Chem Biol. 18:10–24. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Michalet X, Pinaud FF, Bentolila LA, Tsay
JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS and Weiss S:
Quantum dots for live cells, in vivo imaging, and diagnostics.
Science. 307:538–544. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Geissler D, Charbonnière LJ, Ziessel RF,
Butlin NG, Löhmannsröben HG and Hildebrandt N: Quantum dot
biosensors for ultrasensitive multiplexed diagnostics. Angew Chem
Int Ed Engl. 49:1396–1401. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Medintz IL, Uyeda HT, Goldman ER and
Mattoussi H: Quantum dot bioconjugates for imaging, labelling and
sensing. Nat Mater. 4:435–446. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao X, Cui Y, Levenson RM, Chung LW and
Nie S: In vivo cancer targeting and imaging with semiconductor
quantum dots. Nat Biotechnol. 22:969–976. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smith AM, Ruan G, Rhyner MN and Nie S:
Engineering luminescent quantum dots for in vivo molecular and
cellular imaging. Ann Biomed Eng. 34:3–14. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Baiiey RE and Nie SM: Alloyed
semiconductor guantum dots:Tuning the optical properties without
changing the particle size. J Am Chem Soc. 125:7100–7106. 2003.
View Article : Google Scholar
|
|
20
|
Han M, Gao X, Jack Z, Su JZ and Nie S:
Quantum-dot-tagged microbeads for multiplexed optical coding of
biomolecules. Nat Biotechnol. 19:631–635. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wehrenberg BL, Wang CJ and Philippe GS:
Interband and intraband optical studies of PbSe colloidal quantum
dots. J Phys Chem B. 106:10634–10640. 2002. View Article : Google Scholar
|
|
22
|
Mattoussi H, Palui G and Na HB:
Luminescent quantum dots as platforms for probing in vitro and in
vivo biological processes. Adv Drug Deliv Rev. 64:138–166. 2012.
View Article : Google Scholar
|
|
23
|
Dubertret B, Skourides P, Norris DJ,
Noireaux V, Brivanlou AH and Libchaber A: In vivo imaging of
quantum dots encapsulated in phospholipid micelles. Science.
298:1759–1762. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mattheakis LC, Dias JM, Choi YJ, Gong J,
Bruchez MP, Liu J and Wang E: Optical coding of mammalian cells
using semiconductor quantum dots. Anal Biochem. 327:200–208. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pinaud F, King D, Moore HP and Weiss S:
Bioactivation and cell targeting of semiconductor CdSe/ZnS
nanocrystals with phytochelatin-related peptides. J Am Chem Soc.
126:6115–6123. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang T, Zhang Z, Zhang Y, Lv H, Zhou J,
Li C, Hou L and Zhang Q: Dual-functional liposomes based on
pH-responsive cell-penetrating peptide and hyaluronic acid for
tumor-targeted anticancer drug delivery. Biomaterials.
33:9246–9258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Milletti F: Cell-penetrating peptides:
Classes, origin, and current landscape. Drug Discov Today.
17:850–860. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nakase I, Tanaka G and Futaki S:
Cell-penetrating peptides (CPPs) as a vector for the delivery of
siRNAs into cells. Mol Biosyst. 9:855–861. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng CJ and Saltzman WM: Enhanced siRNA
delivery into cells by exploiting the synergy between targeting
ligands and cell-penetrating peptides. Biomaterials. 32:6194–6203.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ezzat K, Zaghloul EM, El Andaloussi S,
Lehto T, El-Sayed R, Magdy T, Smith CI and Langel U: Solid
formulation of cell-penetrating peptide nanocomplexes with siRNA
and their stability in simulated gastric conditions. J Control
Release. 162:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bai H, You Y, Yan H, Meng J, Xue X, Hou Z,
Zhou Y, Ma X, Sang G and Luo X: Antisense inhibition of gene
expression and growth in gram–negative bacteria by cell-penetrating
peptide conjugates of peptide nucleic acids targeted to rpoD gene.
Biomaterials. 33:659–667. 2012. View Article : Google Scholar
|
|
32
|
Nakase I, Akita H, Kogure K, Gräslund A,
Langel U, Harashima H and Futaki S: Efficient intracellular
delivery of nucleic acid pharmaceuticals using cell-penetrating
peptides. Acc Chem Res. 45:1132–1139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu BR, Liou JS, Chen YJ, Huang YW and Lee
HJ: Delivery of nucleic acids, proteins, and nanoparticles by
arginine-rich cell-penetrating peptides in rotifers. Mar Biotechnol
(NY). 15:584–595. 2013. View Article : Google Scholar
|
|
34
|
Liu BR, Huang YW and Lee HJ: Mechanistic
studies of intracellular delivery of proteins by cell-penetrating
peptides in cyanobacteria. BMC Microbiol. 13:572013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Santra S, Yang H, Stanley JT, Holloway PH,
Moudgil BM, Walter G and Mericle RA: Rapid and effective labeling
of brain tissue using TAT-conjugated CdS: Mn/ZnS quantum dots. Chem
Commun (Camb). 3144–3146. 2005. View
Article : Google Scholar
|
|
36
|
Hyndman L, Lemoine JL, Huang L, Porteous
DJ, Boyd AC and Nan X: HIV-1 Tat protein transduction domain
peptide facilitates gene transfer in combination with Cationic
liposomes. J Control Release. 99:435–444. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen B, Liu Q, Zhang Y, Xu L and Fang X:
Transmembrane delivery of the cell-penetrating peptide conjugated
semiconductor quantum dots. Langmuir. 24:11866–11871. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lei Y, Tang H, Yao L, Yu R, Feng M and Zou
B: Applications of mesenchymal stem cells labeled with Tat peptide
conjugated quantum dots to cell tracking in mouse body. Bioconjug
Chem. 19:421–427. 2008. View Article : Google Scholar
|
|
39
|
Xue FL, Chen JY, Guo J, Wang CC, Yang WL,
Wang PN and Lu DR: Enhancement of intracellular delivery of CdTe
quantum dots (QDs) to living cells by tat conjugation. J Fluoresc.
17:149–154. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vives E, Schmidt J and Pèlegrin A:
Cell-penetrating and cell-targeting peptides in drug delivery.
Biochim Biophys Acta. 1786:126–138. 2008.PubMed/NCBI
|
